CSPC Pharmaceutical Group Limited announces that 3 products of the Group are being selected in the tender for national centralized procurement of medicines in China. The three products of the Group are Amoxicillin Capsules, Azithromycin Tablets, and Paclitaxel for Injection (albumin-bound). The other 2 products of the Group namely, Clindamycin Hydrochloride Capsules and Cephalexin Capsules, have not been successfully selected under the tender. The selected prices of each of the Products under the tender are lower than their respective current selling prices in the market. Nonetheless, the Company considers that the Products being successfully selected under the tender will be conducive to expanding sales volume of those products.